"Least-Squares Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A principle of estimation in which the estimates of a set of parameters in a statistical model are those quantities minimizing the sum of squared differences between the observed values of a dependent variable and the values predicted by the model.
| Descriptor ID |
D016018
|
| MeSH Number(s) |
E05.318.740.750.400 N05.715.360.750.695.440 N06.850.520.830.750.400
|
| Concept/Terms |
Least-Squares Analysis- Least-Squares Analysis
- Analyses, Least-Squares
- Least Squares Analysis
- Least-Squares Analyses
- Analysis, Least-Squares
- Analysis, Least Squares
- Least Squares
|
Below are MeSH descriptors whose meaning is more general than "Least-Squares Analysis".
Below are MeSH descriptors whose meaning is more specific than "Least-Squares Analysis".
This graph shows the total number of publications written about "Least-Squares Analysis" by people in this website by year, and whether "Least-Squares Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 4 | 4 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Least-Squares Analysis" by people in Profiles.
-
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study. Blood. 2020 08 06; 136(6):674-683.
-
Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial. PLoS One. 2020; 15(4):e0231000.
-
Artificial intelligence and the analysis of multi-platform metabolomics data for the detection of intrauterine growth restriction. PLoS One. 2019; 14(4):e0214121.
-
Model observer for assessing digital breast tomosynthesis for multi-lesion detection in the presence of anatomical noise. Phys Med Biol. 2018 02 16; 63(4):045017.
-
New statistical methods for estimation of recombination fractions in F2 population. BMC Bioinformatics. 2017 Oct 03; 18(Suppl 11):404.
-
Using rating of perceived exertion in assessing cardiorespiratory fitness in endometrial cancer survivors. Physiother Theory Pract. 2017 Oct; 33(10):758-765.
-
Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes. N Engl J Med. 2017 12 14; 377(24):2337-2348.
-
Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study. Neurology. 2017 May 23; 88(21):2003-2010.
-
Gene transcription profiles associated with inter-modular hubs and connection distance in human functional magnetic resonance imaging networks. Philos Trans R Soc Lond B Biol Sci. 2016 10 05; 371(1705).
-
Exploring the Spatial Association between Social Deprivation and Cardiovascular Disease Mortality at the Neighborhood Level. PLoS One. 2016; 11(1):e0146085.